Skip to main content
. 2017 May 15;11(5):e0005607. doi: 10.1371/journal.pntd.0005607

Fig 3. Strongyloides seroprevalence by month for the baseline cohort and new entrants (excludes results from those that had faecal microscopy/culture, n = 80).

Fig 3